LESLIE B. DANIELS - Corporate Board Profile

Inotiv, Inc.

Filing Date	Source Excerpt
2004-01-20	Leslie B. Daniels joined the BASi Board of Directors in 2003. He was a director of PharmaKinetics Laboratories, Inc., acquired by BASi in 2003. The Board of Directors has established Compensation and Incentive Stock Option, Audit, and Executive Committees. Audit Committee members are not employees of BASi and, in the opinion of the Board of Directors, are independent. The Board of Directors has determined that Leslie B. Daniels is an audit committee financial expert and is independent.
2005-01-19	Leslie B. Daniels joined the BASi Board of Directors in 2003. He is a founding partner of CAI, a private equity fund in New York City. He serves on the Compensation and Incentive Stock Option, Audit, and Nominating Committees. Directors who are not employees of BASi receive $1,500 for each Board meeting attended, plus out-of-pocket expenses. No specific total annual compensation stated.
2006-01-27	Leslie B. Daniels joined the BASi Board of Directors in July 2003. Mr. Daniels is a founding partner of CAI, a private equity fund in New York City. He previously was President of Burdge, Daniels & Co., Inc., a principal in venture capital and buyout investments as well as trading of private placement securities, and before that, a Senior Vice President of Blyth, Eastman, Dillon & Co. where he had responsibility for the corporate fixed income sales and trading departments. Mr. Daniels is a former Director of Aster-Cephac SA, IVAX Corporation, MIM Corporation, Mylan Laboratories, Inc., NBS Technologies Inc. and MIST Inc. He was also Chairman of Zenith Laboratories, Inc. and currently serves as Chairman of Turbo Combustor Technology Inc. and as a Director of SafeGuard Health Enterprises, Inc. Directors who are not employees of BASi receive $1,500 for each Board meeting attended, plus out-of-pocket expenses incurred in connection with attendance at such meetings.
2007-01-18	Leslie B. Daniels joined the BASi Board of Directors in July 2003. Mr. Daniels is a founding partner of CAI, a private equity fund in New York City. He previously was President of Burdge, Daniels & Co., Inc., a principal in venture capital and buyout investments as well as trading of private placement securities, and before that, a Senior Vice President of Blyth, Eastman, Dillon & Co. where he had responsibility for the corporate fixed income sales and trading departments. Mr. Daniels is a former Director of Aster-Cephac SA, IVAX Corporation, MIM Corporation, Mylan Laboratories, Inc., NBS Technologies Inc. and MIST Inc. He was also Chairman of Zenith Laboratories, Inc. and currently serves as Chairman of Turbo Combustor Technology Inc. and as a Director of SafeGuard Health Enterprises, Inc. Compensation: Directors who are not employees of BASi receive $2,000 for each Board meeting attended, plus out-of-pocket expenses incurred in connection with attendance at such meetings.
2008-01-28	Leslie B. Daniels joined the BASi Board of Directors in July 2003. ... The following table shows certain information about the Nominated Directors: Leslie B. Daniels, 60, Director. ... Compensation for non-employee directors during the 2007 fiscal year consisted of the following: ... Leslie B. Daniels, $4,825. ... Committees: Compensation, Audit, Nominating.
2009-02-05	Leslie B. Daniels joined the BASi Board of Directors in July 2003. Mr. Daniels is a founding partner of CAI, a private equity fund in New York City. He previously was President of Burdge, Daniels & Co., Inc., a principal in venture capital and buyout investments. Compensation for non-employee directors during the 2008 fiscal year consisted of the following: Fees paid in cash $6,050; Option Awards $461; Total $6,511.
2010-02-05	Leslie B. Daniels joined the BASi Board of Directors in July 2003. Mr. Daniels is a founding partner of CAI, a private equity fund in New York City, and has served in that capacity for at least the last five years. He previously was President of Burdge, Daniels & Co., Inc., a principal in venture capital and buyout investments as well as trading of private placement securities, and before that, a Senior Vice President of Blyth, Eastman, Dillon & Co. where he had responsibility for the corporate fixed income sales and trading departments. Mr. Daniels is a former Director of Aster-Cephac SA, IVAX Corporation, MIM Corporation, Mylan Laboratories, Inc., NBS Technologies Inc. and MIST Inc. He was also Chairman of Zenith Laboratories, Inc. and currently serves as Chairman of Turbo Combustor Technology Inc. and as a Director of SafeGuard Health Enterprises, Inc. and Aerosat, Inc. ... Committees: Compensation, Audit, Nominating. ... Compensation for non-employee directors during the 2009 fiscal year: Fees paid in cash $3,650, Total $3,650.
2011-01-28	Leslie B. Daniels (2) Mr. Daniels resigned as a director on October 5, 2010.